Health
Psychedelic drug discovery enabling discovery of new psychiatric drugs – Drug Target Review
Having resolved the structure of psychedelic drugs bound to the 5-HT2A serotonin receptor researchers are developing new therapeutic drugs.
Posted: 18 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Having resolved the structure of psychedelic drugs bound to the 5-HT2A serotonin receptor researchers are now developing new therapeutic drugs.
Psychedelic drugs such as LSD, psilocybin, and mescaline cause severe and often long-lasting hallucinations, but also show great potential in treating serious psychiatric conditions, such as major depressive disorder. In order to understand their therapeutic effect, and p…
-
Noosa News12 hours agoTwo in five Brisbane streets have no footpaths, with council building about 4km of new paths last year
-
Business21 hours agoWhere to invest $20,000 in ASX ETFs for 2026 and beyond
-
General20 hours agoReece Walsh grabs the Sun to lead Brisbane to an all-time victory over Canberra
-
General19 hours agoBritish boxer and former world champion Ricky Hatton dies at age 46